aap Launches 1st Human Clinical Study for Antibacterial Coating

By Julie A. Vetalice

aap Launches 1st Human Clinical Study for Antibacterial Coating

aap Implantate announced that the human clinical study for its innovative antibacterial silver coating technology has commenced.

aap is reportedly the first company in the world to test an antibacterial silver coating on anatomical plates and screws for fracture treatment as part of a study of this kind.

With its antibacterial silver coating technology, aap addresses the reduction of surgical site infections (SSI) in traumatology. The coating technology represents an alternative solution in the fight against bacterial infections that is not based on antibiotics and therefore offers enormous market potential. As a platform technology, the technology has a broad range of applications and can be used not only in traumatology but also in other areas of orthopedics as well as in cardiology, dentistry or medical instruments.

In the future, aap will report regularly on the progress of the human clinical study for its innovative silver coating technology.

Source: aap Implantate

Product Labels: Lower Extremity

Tags: Trial/Study